PRMT5 and cancer: Previous studies have shown that PRMT5 is overexpressed in several types of cancers, and that PRMT5 inhibition and knockdown resulted in a substantial decrease in cellular proliferation, migration, and colony-forming abilities, as well as increases in apoptosis and cell cycle arrest, in both in vitro and in vivo studies [24,25,26].